Additional Info: Antibodies to SCL-70 are a specific marker for Scleroderma and are found in 20-60% of Scleroderma patients.
Useful For: Scleroderma may be localized or diffuse [Progressive Systemic Sclerosis (PSS)] that may involve skin, gastrointestinal tracts, lungs, vascular and cardiac systems, and kidneys. SCL-70 Antibody is present in approximately 40% of patients with PSS.
Methodology: Immunoassay
Specimen Requirements: 1 yellow-top SST tube (minimum: 0.5 mL of serum). Centrifuge SST 30 minutes after draw. Refrigerate specimen after collection.
NOTE: Gross hemolysis, lipemia and icterus conditions may affect results.
Analytical Time:
3 days
Days Set Up: Monday through Friday
CPT Information:
86235 –